Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Paclitaxel
Related studies linked through entity extraction aliases.
Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy
- Status
- COMPLETED
- Phase
- PHASE2
Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2